Image -
IWATA, September 1, 2017 - Yamaha Motor Co., Ltd. (Tokyo:7272) announced today that it has developed the Cell* Picking & Imaging System CELL HANDLERTM. This device performs part of the testing process to evaluate pharmaceutical efficacy, such as in the development of new drugs and anti-cancer agents. The first unit was delivered to Fukushima Medical University on August 31, 2017.
*In this r
Yamaha Motor (TOKYO: 7272) is a world-leading enterprise manufacturing land-mobility such as motorcycles, all-terrain vehicles, and electrically power assisted bicycles, marine products such as boats and outboard motors, robotics products such as surface mounters and drones, as well as engagement in the finance business. The company's diverse businesses and wide variety of products are built around its proprietary technologies focused on powertrain, chassis and hull, electronic control, and manufacturing technologies. Yamaha Motor operates global development, production and sales networks through 140 subsidiaries and equity-method affiliates in 30 countries and regions, working to realize our Corporate Mission of being s "Kando* Creating Company."
About 90% of consolidated net sales are generated in more than 180 countries and regions outside of Japan.
Please visit http://global.yamaha-motor.com.
*This is a dedicated website providing Yamaha Motor PR materials for viewing by media journalists.
We request that you refrain from using the materials and photographs on this website for purposes other than media reporting.
